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Spinocerebellar Ataxia type 7 (SCA7) is a neurodegenerative disease caused by
expansion of a CAG repeat encoding a polyglutamine tract in ATXN7, a
component of the SAGA histone acetyltransferase (HAT) complex.

Previous

studies provided conflicting evidence regarding the effects of polyQ-ATXN7 on
the activity of Gcn5, the HAT catalytic subunit of SAGA. Here I showed that
reducing Gcn5 expression accelerates both cerebellar and retinal degeneration
in a mouse model of SCA7. Deletion of Gcn5 in Purkinje cells in mice expressing
wild type Atxn7, however, causes only mild ataxia and does not lead to the early
lethality observed in SCA7 mice. Reduced Gcn5 expression strongly enhances
retinopathy in SCA7 mice, but does not affect the transcriptional targets of Atxn7,
as expression of these genes is not further altered by Gcn5 depletion. These
findings demonstrate that loss of Gcn5 functions can contribute to the time of
onset and severity of SCA7 phenotypes, but suggest that non-transcriptional
functions of SAGA may play a role in neurodegeneration in this disease.
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Chapter I

Background and Significance

1

Gcn5 is a histone acetyltransferase (HAT) that catalyzes protein acetylation
and is important for gene regulation in many cells in the body. However its
functions in neurons were unknown at the beginning of my studies. Evidence that
I provide here regarding the role of Gcn5 in a neurodegenerative disease,
Spinocerebellar Ataxia type 7 (SCA7), and in neurons strongly suggests that
Gcn5 not only functions in the neurons but is also central to neurotoxicity
observed in SCA7.

Potential role of Gcn5 in Spinocerebellar Ataxia type 7 (SCA7)
SCA7 is one of 9 inherited polyGlutamine (polyQ) expansion
neurodegenerative diseases. Most SCA7 patients develop adult onset of
progressive neurological symptoms that are linked to cerebellar, brainstem, and
retinal neurodegeneration. The symptoms include ataxia, dysarthria, dysphagia,
slow eye movement associated with brainstem dysfunctions, and decreased
visual acuity (David et al., 1997; David et al., 1998; Giunti et al., 1999).
All SCA7 patients develop progressive ataxia. Cerebellar degeneration is
responsible for the uncoordinated movement, since the cerebellum controls
motor coordination for limb movement and posture maintenance (David et al.,
1998). Gross cerebellar atrophy is generally observed in SCA7. Among all cell
types, Purkinje cell degeneration was most profound in the cerebellum of SCA7
patients (Carpenter and Schumacher, 1966; Gouw et al., 1994; Jobsis et al.,
1997; Martin et al., 1994; Rub et al., 2005). Purkinje cells align into one cell layer
(Purkinje cell layer, PCL) between the molecular layer (ML) and granule cell layer

2

(GCL) in the cerebellum. The dendrites of Purkinje cells stretch and form
synaptic connections in the molecular layer, while their axons pass through the
granule cell layer and the white matter to connect to cerebellar and vestibular
nuclei as the sole output of the information processed in the cerebellum.
Therefore degeneration of Purkinje cells disturbs cerebellar functions.

As a result of retinal dysfunction and degeneration, SCA7 patients develop
progressive loss of color vision and visual acuity in addition to cerebellar ataxia
(David et al., 1997; Gouw et al., 1994). Retinal degeneration is a unique feature
of SCA7 among all spinocerebellar ataxias (Enevoldson et al., 1994; Neetens et
al., 1990). Retinography and pathological analysis indicate that the
photoreceptors, the cell types responsible for receiving light, are the most
affected cell types in the retinas of SCA7 patients (Aleman et al., 2002; Martin et
al., 1994; Michalik et al., 2004; Neetens et al., 1990; Rub et al., 2005).

The cause of SCA7 is an expansion mutation of CAG repeats in the 2nd exon
of one allele of ATXN7 (Krols, 1997; David, 1997). Repeats longer than 35 CAGs
in ATXN7 lead to neurodegenerative symptoms (David et al., 1998; Giunti et al.,
1999). The length of polyCAG correlates to the onset and progression of the
neurological symptoms and degeneration of SCA7 (Giunti et al., 1999). This
correlation suggests that the longer the polyCAG repeat in ATXN7, the stronger
the neurotoxicity it bears. In very rare cases, repeats longer than 100 CAGs
cause infantile forms of SCA7, in which patients develop neurodegeneration and
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lethality within two years of age (Grattan-Smith et al., 2001; Tsivgoulis et al.,
2008; van de Warrenburg et al., 2001).

As an in-frame mutation, the expanded CAG repeat is translated into an
expanded polyGlutamine (polyQ) tract that tends to fold into beta-sheets in the Nterminal region of polyQ-Atxn7 protein. This beta-sheet folding of the polyQ
stretch causes polyQ-Atxn7 to aggregate into nuclear inclusions (NIs). The
aggregative feature of polyQ-protein was thought to link to an aberrant gain-offunction that leads to neurodegeneration. However, since Atxn7 is ubiquitously
expressed in most cell types, and polyQ-ATXN7 nuclear inclusions were
observed in many non-degenerative cell types in clinical studies, NIs were later
proposed to be a cellular protective response to the mis-folded protein (Holmberg
et al., 1998; Jonasson et al., 2002).

To date, how ubiquitously expressed polyQ-Atxn7 specifically causes
neurotoxicity is unclear. SCA7 patients still await effective therapeutics. Although
clinical case reports and pathological findings thoroughly described the change in
degenerative sites, most of this information was obtained at terminal stages of
the disease. As a result, clinical studies have provided very limited information to
the molecular mechanisms of how polyQ-Atxn7 causes neurotoxicity and disease
progression. Therefore, using animal models to define the cause of neurotoxicity
is crucial for uncovering the mechanisms of SCA7 neuropathogenesis at early
stages.
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Since Atxn7 does not carry enzymatic activities, the mechanism underlying
SCA7 has been pointed to its interactors. Atxn7 is known to be part of a multicomponent complex, SAGA, which carries protein-modifying activities
(Helmlinger et al., 2004b). This suggests the neurotoxicity could be linked to
abnormal SAGA functions. Most SAGA components are highly expressed in the
cell types that are most affected in the cerebellum (Table 1), suggesting function
of SAGA is conserved in these cells. Here I provide evidence on the role of
Gcn5, one of the enzymatic components of SAGA, in the cerebellum in the
central nervous system (CNS) and the retina in the peripheral nervous system
(PNS) since these two sites are specifically affected in the SCA7.

General information about Gcn5
To further understand the neuronal functions of Gcn5, next I will introduce
known functions of Gcn5.

The highly conserved sequence among eukaryotes suggests Gcn5 carries
important roles. In mice, Gcn5 is located on chromosome 11. Alternative splicing
of this gene results in two different Gcn5 transcripts, a long and a short Gcn5
form (Gcn5L and Gcn5S; (Xu et al., 1998). Both forms are translated into
polypeptides. Gcn5L is composed of three conserved domains: a PCAF N-
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Table 1: Expression pattern of components of SAGA and ATAC in the
mouse hindbrain

6

terminal-like domain, a NAT_SF, and a bromo domain (Figure 1), while Gcn5S
contains only NAT_SF and a bromo domain (Xu, 1998 et al.; Conserved Domain
Database, NCBI). The PCAF N-terminal domain has no known functions and is
only conserved in metazoans. The NAT_SF super family domain carries HAT
activity, and the bromo domain binds to acetylated lysines, and also facilitates
acetylation of nucleosomes in yeast (Li and Shogren-Knaak, 2009).

Histone acetyltransferase activity of Gcn5 and protein acetylation.
With the NAT_SF domain, Gcn5 carries HAT activity. Among five families of
HATs, Gcn5 belongs to the Gcn5-related N-acetyltransferase (GNAT) family that
also includes Pcaf, Hat1, Elp3, and Hpa2. All the HATs of GNAT family are
localized to and functions within the nucleus (reviewed by Roth et al., 2001).
Although originally found to acetylate histones, HATs also acetylate nonhistone proteins. HATs transfer the acetyl group from acetyl-CoA to the ε-amine
on lysine residues on proteins and therefore are also known as lysine (K)
acetyltransferases (KATs) (Hodawadekar and Marmorstein, 2007; Roth et al.,
2001). Adding an acetyl group abrogates the positive charge of lysine.

Lysine acetylation occurs on histones, transcription factors, nuclear
receptors, high mobility group proteins, and α-tubulin. The most abundant cellular
acetylated proteins are histones and tubulin. Histone acetylation has been
studied more intensively because of its important functions in packing the genetic
material, DNA. To utilize the limited space in the nucleus, the positive-charged
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Figure 1. Structure of mouse Gcn5 gene and polypeptide product
Diagram shows structure of mouse Gcn5 gene and expressed polypeptide
product. Open and dark blue boxes represent untranslated region and exons of
Gcn5. Gcn5 gene product is a polypeptide of 830 amino acids. Blue, orange, and
red boxes represent PCAF_N, NAF_SF, and bromo domains.
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Figure 1

9

histones H2A, H2B, H3, and H4 are assembled into octamers for negativecharged DNA to wrap around and form the core nucleosomes. Nucleosomes can
then pack into higher order chromatin structures. Upon transcription, genomic
DNA needs to be “opened up” at the level of chromatin, evicting or increasing
accessibility of nucleosomes to the transcriptional machinery. Acetylation on
various lysines in the histone tails of H2A, H2B, H3 and H4 decreases the
positive charge, freeing the histone tails from holding DNA (reviewed by
Kouzarides, 2007). In addition to changing chromatin architecture, the acetyllysines on histone tails also create docking sites for proteins containing bromo
domains that bind specifically to acetyl-lysine (Dhalluin et al., 1999; Kanno et al.,
2004). As a result, acetylated histones H3 and H4 at the promoter regions of
genes are associated with transcriptional activation.
As a HAT, Gcn5 acetylates both histones and non-histone substrates. Gcn5
acetylate histones on its N-terminal tails. In metazoans, histone H3 lysine 9
(H3K9), 14 (H3K14), 56 (H3K56), histone H4 lysine 8 (H4K8), 16 (H4K16), and
H2A/B are acetylated by Gcn5 (Kuo et al., 1996). During transcription,
transcription activators such as c-Myc and TNFβ, recruit Gcn5 to nucleosomes to
catalyze histone acetylation on the chromatin and facilitate transcription
(transcription targets of Gcn5 are summarized in Table 2). By participating in the
transcriptional coactivation of various genes, Gcn5 regulates a wide range of
cellular processes. In addition to histone substrates, as a nuclear HAT, Gcn5
also acetylates nuclear proteins such as transcription factors and cell cycle
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Table 2: Transcriptional targets of Gcn5

Role
Coactivator

Transcriptional Organism
targets
pho8, his3,
Yeast
gal1, arg1

Yeast

SAGA/ATAC

References

NA

Gregory, 1999;
Filetici, 1998;
Kuo, 1998;
Natarajan, 1999;
Govind CK,
2007
Flinn, 2002;
Barbaric, 2003;
Brown, 2001
Yanagisawa,
2002

Myc coactivation

pho5

ER coactivation

Cathepsin, c-fos Human

SAGA

Retinoic acid (RAR)
coactivation

NA

Human

SAGA

Brown, 2003

Myc coactivation

MYC-r element

Human

SAGA

Liu, 2003

P53 coactivator

P21, GADD45

Human

SAGA

TGF-β
β /smad
coactivator

PAI-1

Human

NA

An, 2004;
Gamper, 2008,
2009
Kahata, 2004

Crx coactivation

Sop, Mop,

Mouse

NA

Peng, 2007

Pol III/c-Myc
coactivator

tRNA, 5S rRNA

Human

TRRAPcontaining

Kenneth, 2007

Wnt/β
β-catenin
signaling

SIAMOIS
reporter

Human

NA

Sustmann, 2008

Stress response:
Sty1- and Atf1coactivator

gpd1, ctt1,
hsp9, srx1

Yeast

NA

Sanso, 2011

NA: not applicable
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SAGA

regulators. The acetylation catalyzed by Gcn5 changes the stability or activity of
the substrate proteins (summarized in table 3). In mammalian cells, Gcn5mediated acetylation of Myc, c/EBPbeta, and GATA-2 increases the activity of
these transcription factors (Faiola et al., 2005; Hayakawa et al., 2004; Patel et
al., 2004; Wiper-Bergeron et al., 2007). On the other hand, PGC1a, PGC1b and
CDK9 transcriptional activity is decreased after being acetylated by Gcn5 (Kelly
et al., 2009; Lerin et al., 2006; Sabo et al., 2008). Gcn5 acetylation on CDC6 and
CyclinA decreases stability of these proteins (Orpinell et al., 2010; Paolinelli et
al., 2009). By altering the functions of these transcription factors and cell cycle
regulators, Gcn5 is also involved in controlling various pathways.

Although Gcn5 was found as a nuclear HAT, a few recent papers suggest the
possibility that GCN5 acetylates α-Tubulin that is located mainly in the cytosol
(Conacci-Sorrell et al.; Orpinell et al., 2010). However how this nuclear HAT
acetylates α-Tubulin remains unclear.

Gcn5 HAT-independent functions
Although well studied as a HAT, previous genetic findings from the Dent Lab
suggests Gcn5 also functions in a HAT-independent manner. The Gcn5 HAT
catalytic mutant shows later lethality than Gcn5 null mice, suggesting that Gcn5
also has functions independent of its HAT activity (Bu et al., 2007; Xu et al.,
2000). Recently, Gcn5 was found to regulate NFκB-mediated transcription
independent of its HAT function by associating with COMMD1, an ubiquitin
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Table 3: Substrates of Gcn5

Protein
targets
MYC

Organism

SAGA/ATAC Reference

Human

SAGA

Faiola, 2005;
Patel, 2004

Haemotopetic stem
cell differentiation

GATA-2

Human

NA

Hayakawa, 2004

Glucose
metabolism

PGC1a

Human

NA

Lerin, 2006

Glucocorticoidstimulated
preadipocyte
differentiation

C/EBPbeta

Human

NA

Wiper-Bergeron,
2007

Human

NA

Sabo, 2008

Role
Myc:Max activity

Disrupt activity of P- CDK9
TEFb
Glucose
metabolism

PGC1b

Human

NA

Kelley, 2009

Regulates S phase

CDC6

Human

NA

Paolinelli, 2009

Degradation-Mitotic
progression

CyclinA

Human

ATAC

Orpinell, 2010

Tubulin dynamics

α-Tubulin

Human

NA

Conacci-Sorrell,
2010
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ligase, and facilitating its activity (Mao et al., 2009). However clear mechanisms
of how HAT-independent functions of Gcn5 regulate cellular pathways still
remains unclear. In addition, Gcn5 is also required for the full activity of another
enzymatic component of the SAGA complex, the Usp22 deubiquitinase
(Atanassov et al., 2010).

Gcn5 is a component of multicomponent complexes
Gcn5 is known to function as part of two distinct multicomponent complexes,
ATAC and SAGA (Grant, 1997; Eberharter, 1999; Martinez, 1998; Ogryzko,
1998; Matrinez, 2001; Guelman, 2009; Gamper, 2009). ATAC and SAGA share
many components such as Trrap and Ada3. However these two complexes also
have distinct components that define substrates and cellular functions. Most
components of SAGA are expressed in the cerebellum. The components of
ATAC and SAGA and their expression pattern in the cerebellum are summarized
in Table 1.

The ATAC complex uniquely contains Ada2a, Wdr5, Dr1, Mbip, Yeats2, and
Mocs2, making it distinct from SAGA. Gcn5 in the ATAC complex preferentially
acetylates histone H4, although it also acetylates histone H3 (Guelman et al.,
2009). The ATAC complex is also known to be involved in cell cycle progression
via acetylation of non-histone substrates including CyclinA (Orpinell et al., 2010).
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The SAGA (Spt-Ada-Gcn5-acetyl-transferase, also as known as TFTC)
complex contains Ada, Spt, Taf II proteins, and a deubiquitinase (DUB)
submodule. Gcn5 within SAGA preferentially acetylates histone H3 and H2B, and
has stronger activity towards chromatin than free histones as part of the SAGA
complex (Gamper et al., 2009; Grant et al., 1999).

The SAGA DUB submodule includes Usp22, Eny2, Atxn7l3, and Atxn7.
Usp22 is the deubiquitinase catalytic subunit but is only active as part of the DUB
module (Zhao et al., 2008). The deubiquitination of histone H2B catalyzed by the
DUB module is required for nuclear receptor coactivation (Zhang et al., 2008;
Zhao et al., 2008). The DUB activity of USP22 also regulates protein stability of
telomeric shelterin protein, TRF1 (Atanassov et al., 2009). Eny2 is also part of a
nuclear pore complex and may connect the function of SAGA to RNA export in
yeast (Cabal, 2006; Krushavika, 2007). Both Atxn7 and Atxn7l3 contain a SCA7
domain and one C2H2 zinc-finger domain that connects the DUB module to
SAGA. The diverse amino acid sequences in the SCA7 domains of Atxn7 and
Atxn7l3, however, form distinct conformations. As a result, only the SCA7 domain
in Atxn7 facilitates binding to nucleosomes (Bonnet et al., 2010). Although their
structures have been solved, the molecular functions of Atxn7 and Atxn7l3 are
still unknown. However, SCA7, a human inherited disease caused by mutation in
ATXN7, gives a hint to its biological role. Since SCA7 is caused by polyCAG
expansion mutations in ATXN7, the neuronal defects in SCA7 suggests the

15

important role of Atxn7 in maintaining neuronal functions and survival, likely
through affecting functions of SAGA.

Physiological roles of Gcn5
Although yeast model system provided nice evidence for Gcn5 functions, in
mammalian systems, most of the cellular functions of Gcn5 were defined using
transformed cell lines. Since lacking evidence from mammalian tissue, the
physiological roles of Gcn5 have not yet been defined clearly.

The ubiquitous expression of Gcn5 through out mouse development suggests
its functions are widely utilized in most cell types. Among all tissues, Gcn5 is
most abundant in embryos and in brains of adult mice (Xu et al., 1998). In the
central nervous system (CNS) and peripheral nervous system (PNS), the
expression level of Gcn5 is most strong in three sites, hippocampus of the
forebrain, Purkinje cell layer in the hindbrain, and the dorsal root ganglia of the
spinal cord in mice (RNA in situ database from Allen Brain Institutes).
Interestingly, most of the SAGA components exhibit a similar expression pattern
(Table 1; RNA in situ database from Allen Brain Institutes), suggesting conserved
functions of SAGA in CNS cells.

Gcn5 functions during development
Corresponding to its high expression levels in embryos, Gcn5 is essential for
early embryonic development. Mice lacking Gcn5 die by embryonic day 10.5
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(E10.5) (Xu et al., 2000). Gcn5 HAT activity also plays an essential role in neural
tube closure (Bu et al., 2007). In addition to functions in neural development,
proper levels of Gcn5 are also essential for correct rib and skeletal patterning in
the mouse (Lin et al., 2008).

The deleterious phenotypes of Gcn5 mutants not only suggest the importance
of functions of Gcn5 during development, but also suggest the reason why no
human inherited disease is directly associated with Gcn5 mutation.

Potential neuronal functions of Gcn5 in adult mammals
Little is known about Gcn5 functions in adult tissues. The only previous
evidence provided comes from Gcn5 hypomorphic (Gcn5fn/fn) mice that express
~20% normal cellular levels of Gcn5. Only 10% of the Gcn5fn/fn mice survive till
adulthood (Lin et al., 2008). These surviving Gcn5fn/fn mice developed defects
including ptosis (droopy eyes) and kyphosis (hunched posture) as they aged (Lin,
unpublished data). Interestingly, this abnormal appearance resembles that in a
mouse model of SCA7, which is caused by polyQ-Atxn7 (Yoo et al., 2003). In
SCA7, adult onset ptosis and kyphosis are associated with retinal and cerebellar
degeneration, respectively. As previously mentioned, both Atxn7 and polyQAtxn7 can incorporate into SAGA. Therefore the phenotypes in Gcn5
hypomorphic mice urge the question whether Gcn5 plays an important role in
maintaining healthy retina and cerebellum in adult mammals.
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Transcriptional down regulation is associated with altered Gcn5 functions
in SCA7 retina
Overexpression of polyQ-Atxn7 in yeast and in cultured human cell lines
suggested that both Atxn7 and polyQ-Atxn7 incorporate into the SAGA complex.
Some reports indicate that the incorporation of polyQ-Atxn7 reduces histone
acetyltransferase (HAT) activity of SAGA complex (Helmlinger et al., 2006b;
Helmlinger et al., 2004b; McMahon et al., 2005b). Since Gcn5 is the only
component that carries HAT activity in SAGA, these data first suggested that
polyQ-Atxn7 could hinder functions of Gcn5/SAGA, leading to cell toxicity.

Multiple SCA7 animal models show that polyQ-Atxn7 causes neurotoxicity
(Garden et al., 2002; La Spada et al., 2001; Latouche et al., 2006; Yoo et al.,
2003; Yvert et al., 2000; Yvert et al., 2001). Mice bearing one allele of 266
repeats of polyCAG in Atxn7 recapitulate neurodegenerative phenotypes of the
infantile form of SCA7, providing further evidence for polyQ-Atxn7 neurotoxicity.
In these Atxn7266Q/5Q mice, transcriptional down-regulation of photoreceptorspecific genes was associated with the early dysfunction and degeneration of
photoreceptors (Yoo, 2003). Since Gcn5, as part of SAGA, functions as a
transcription coactivator and interacts with polyQ-Atxn7, the transcriptional downregulation in the polyQ-Atxn7 neurons may result from dysfunction of Gcn5.
(Helmlinger et al., 2006a; La Spada et al., 2001; Palhan et al., 2005; Yoo et al.,
2003). Consistent with this idea, previous work from two different groups
indicates that altered function of Gcn5 strongly associates with this transcriptional
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down regulation in early degenerating retina of two transgenic SCA7 models.
Palhan et al showed that along with the transcriptional downregulation, hypo
acetylated histones are enriched at gene promoters, and that Gcn5 has reduced
HAT activity when polyQ-Atxn7 incorporates into SAGA. However another study
provided contradictory evidence of change in function of Gcn5 (Helmlinger et al.,
2006a; Palhan et al., 2005). In their polyQ-Atxn7 transgenic mice, Helmlinger et
al found that polyQ-Atxn7-containing SAGA has no less HAT activity of Gcn5.
Surprisingly, they also observed higher levels of SAGA enrichment along with
hyperacetylated histones at the promoters of affected genes. An aberrant hyperacetylated genome was proposed to alter the structure of heterochromatin and
change the distribution of RNA polymerase II. Although still inconclusive, this
evidence suggests that altered Gcn5 functions play a key role in primary
neurotoxicity of SCA7. However more evidence is needed to address how altered
function of Gcn5 contributes to neurodegeneration in SCA7.

Goal and Significance
Current knowledge for physiological roles of Gcn5 in the mammalian nervous
system is only to the stage of neurulation (Lin, 2007; Bu, 2008). Although
suggested by observations in SCA7 models, whether Gcn5 is important for
biological functions in postmitotic neurons still remains unclear. Since Gcn5 is
expressed highly in adult neurons, I hypothesized that Gcn5 supports normal
functions of mature cerebellar and retinal neurons and that Gcn5
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dysfunction impairs cerebellar and retinal functions, which contributes to
ataxia and neurodegeneration in Spinocerebellar Ataxia type-7.

To this end, I asked whether Gcn5 loss-of-function contributes to SCA7
neurodegeneration by genetically testing if reducing Gcn5 expression leads to
more severe degeneration in a SCA7 mouse model. I also tested whether Gcn5
is essential in maintaining mature neuron functions by reducing Gcn5 specifically
in neurons using mouse genetics. Together this study provides the first view of
Gcn5 functions in mature neurons and provides new insights into possible
therapeutic options for SCA7.
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Chapter II

Materials and Methods
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Generation of Gcn5;Atxn7 and Purkinje cell-specific Gcn5 mutant mouse
models
Atxn7 230Q and Atxn7 100Q alleles were naturally occurring, contracted
mutations of the 266Q tract in Atxn7 obtained during maintenance of the
Atxn7266Q/5Q mouse line (Yoo et al., 2003). Atxn7100Q/5Q;Gcn5fn/+ or
Atxn7100Q/5Q;Gcn5∆/+ mice were generated by crossing Gcn5flox(neo)/+ or Gcn5∆3-18/+
mice (Lin et al., 2007) with Atxn7100Q/5Q mice. Atxn7100Q/5Q;Gcn5fn/fn mice were
generated by crossing Gcn5fn/+ and Atxn7100Q/5Q;Gcn5fn/+ mice.
Atxn7100Q/100Q;Gcn5∆/+ mice were generated by crossing Atxn7100Q/5Q;Gcn5∆/+ and
Atxn7100Q/5Q mice.
Purkinje cell-specific Gcn5 conditional nulls were obtained from crossing
Gcn5∆/+ mice that carry Pcp2-cretg (Barski et al., 2000; Barski et al., 2002) with
Gcn5flox/flox mice. Genotyping for Gcn5 alleles and Atxn7 alleles was performed
using PCR primers as previously described (Lin et al., 2007; Yoo et al., 2003).
Pcp2-cre genotype was assessed following the protocol for generic Cre by JAX
lab website
(http://jaxmice.jax.org/protocolsdb/f?p=116:2:3402763281359342:NO2:P2_MAS
TER_PROTOCOL_ID,P2_JRS_CODE:288,004146). All procedures were
performed in accordance with the approved IACUC protocols at MDACC.

Generation of Gcn5fn/fn mice
Gcn5fn/fn mice were generated by intercrossing Gcn5fn/+ males and females.
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Survival analysis
PolyQ-Atxn7 mutant mice were housed with control littermates and given ad
libitum supply of moist food upon ataxia as diagnosed. Moribund was defined by
losing body weight of more than 20%, or loss of mobility. Statistical significant
differences of lifespans were determined by Kaplan-Meier test.

Histological analyses
Mice were first anesthetized by intra peritoneal injection of Avertin. Deeply
anesthetized animals were transcardially perfused with PBS followed by 4%
paraformaldehyde. Isolated organs were fixed in 4% paraformaldehyde
overnight. Fixed tissues were then preserved in paraffin or cryo- blocks. For
hematoxylin and eosin Y staining (H&E), 6 µm sections of paraffin-embedded
mid-sagittal brain or eye were stained with H&E staining protocol (Fisher).
Pictures were taken using Olympus SZX12 or Leica DM4000 microscope. For
Immunofluorescent staining, 20 µm sections of cryo-preserved tissues were
used. Briefly, sections were boiled in 10 mM sodium citrate to retrieve antigen.
0.2% PBST was used for permeablizing and washing prior to incubation in antiGcn5 (Cell Signaling, 1:150), anti-Ataxin7 (Fisher, 1:250), anti-Calbindin (1:1000,
Sigma) and anti-GFAP antibody (1:600, Dako). Signals were visualized using
Alexa 555 -conjugated donkey anti-mouse or Alexa 488-conjugated donkey-anti
rabbit antibody (all 1:750, Invitrogen). DAPI (Roche) counterstains the nucleus.
All pictures were obtained using FV1000 Olympus confocal microscope.
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Purkinje cell counts were done by counting nuclei of Purkinje cells in pictures of
H&E-stained 6 µm mid-sagittal cerebellar sections (three sections per mouse)
from 3-4 mice each genotype using Image J software (National Institutes of
Health). Samples were renumbered to avoid bias. Statistical significance was
determined using Student’s t tests.

Quantification Purkinje cell soma size. Purkinje cell perikaryons were
manually outlined from 12 µm z-stacked images of Calbindin1-labeled midsagittal cerebellums (3-4 images each mouse) using Image J software (National
Institutes of Health). A total of 135 cells in lobule VI from 2-3 animals were
analyzed for each genotype.

Electron Microscopy
Mice were intracardially perfused with 1.5% glutaldehyde plus 2 %
paraformaldehyde after being deeply anesthetized by Avertin. Tissues were
collected and sent to the High Resolution Electron Microscopy Facility,
UTMDACC for further processing.

Footprint analyses
Behavioral tests were performed between 2-6 p.m. with animals maintained
on a C57BL/6J:129/SvEv mixed background at F3 or F4 backcrossing to
C57BL/6J.
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Footprint analysis was done as previously described (Carter et al., 1999). Briefly,
fore- and hind- paws of mouse were painted with nontoxic red and blue paints.
Then the mouse was allowed to walk through a tunnel (17-inch-long, 3-inch-wide,
3-inch height) lined with a fresh paper at the bottom for each test. Statistical
difference was first tested using one-way ANOVA between males and females.
Data were only pooled together when there is no difference between genders.
Statistical significant difference was determined by Kruskal-Wallis test.

Wirehang test
Wirehang test was performed following Shahbazian et al, 2002. Briefly, mice
were habituated 2 minutes on a darkened platform (3 inch2) to establish a safety
area before test. Each mouse was then allowed both fore paws to grab a 2.5 mm
plastic wire attached to the platform. The time takes for the animal to reach the
safety area, and the latency to fall were recorded. Three animals were tested for
each genotype. The difference of time to fall among genotypes was calculated
using non-parametric Kruskal-Wallis test.

Dowel test
Dowel test was performed following Shahbazian et al, 2002. Briefly, mice
were habituated 2 minutes on a darkened platform (3 inch2) to establish a safety
area before test. Each mouse was then allowed to land on the center of a
horizontal 0.7 mm wooden dowel attached to the platform. The time takes for the
animal to reach the safety area, and the latency to fall was recorded. Three
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animals were tested for each genotype. The difference of time to fall among
genotypes was calculated using non-parametric Kruskal-Wallis test.

Rotarod test
All mice were habituated for 7 consecutive days on the rotarod apparatus
(IITC Life Science) before experimental trails. 4 tests were run each day for 4
consecutive days. Latency to fall was recorded by embedded timer triggered
upon animal fell onto the floor plate. Three animals were included for each
genotype. The difference of latency to fall among genotypes was calculated
using non-parametric Kruskal-Wallis test.

Northern blot analysis
Total RNA was extracted using TRIZOL Reagent (Invitrogen) according to the
instructions of manufacturer. 20 µg of total RNA was run on denaturing agarose
then transferred to Hybond-N membrane for each sample. The membrane was
then incubated with pre-hybridization buffer at 68°C for 2 hrs before hybridization
at 68’C overnight with denatured probes. All oligonucleotide probes were
generated with Rediprime II random prime labeling with [32P]dCTP and
linearized plasmid containing T7/T3 promoter and probe sequence. Gcn5 probe
was generated following Xu et al, was used. Actin probe was used as internal
control.

Quantitative RT-PCR and primers
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All tissues were dissected and snap frozen in liquid nitrogen at 5-8 p.m. after
overdose anesthesia with Avertin. Total RNA was prepared using TRIZOL
Reagent (Invitrogen) according to the instructions of manufacturer followed by on
column DNase I (Qiagen) treatment. cDNAs were generated using 200 ng of total
RNA by SuperScript III reverse transcriptase (Invitrogen) with poly dT primers
following the instructions of manufacturer. cDNA were quantified using specific
primers and SYBR Green PCR Master Mix (Applied Biosystems). Triplicates
were performed. βActin was quantified as normalizing control. The mean value
for three animals was used for the level of each genotype. Statistical difference
was calculated using Student’s t test. Primers used:
Gcn5-f: 5’- CAGTGGTGG AGGGGTCTCTA -3’;
Gcn5-r: 5’- AAACATTGTCTGGCGCTCTC-3’;
Actb-f: 5’- GGCTGTATTCCCCTCCATCG -3’;
Actb-r: 5’- CCAGTTGGTAACAATGCCATGT-3’;
S-opsin-f: 5’– CAGCCTTCATG GGATTTGTCT -3’;
S-opsin-r: 5’– CAAAGA GGAAGTATCCGTGACAG -3’;
M-opsin-f: 5’– ATGGCCCAAAGGCTTACAGG -3’;
M-opsin-r: 5’– CCACAAGAATC ATCCAGGTGC -3’;
rhodopsin-f: 5’– CCCTTCTCCAACGTCACAGG -3’;
rhodopsin-r: 5’– TGAGGAAGTTGATGGG GAAGC -3’;
Grk-f: 5’– CGGGGCAGTTTTGACGGAA -3’;
Grk-r: 5’- AGCTGA GGTTGTCACGGAGA -3’;
Rom1-f: 5’- CTCCAACCCCGT ATCCGTTTG -3’;
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Rom1-r: 5’- GAGCAGGGAATGAACAAGAGG -3’;
Cnga3-f: 5’ –TCGACCAC GTAGAGAACGG -3’;
Cnga3-r: 5’ – TGGAGGGGTCCACCACAAT -3’;
Rbp3-f: 5’- ATGAGAGAATGGGTCCTGGTT -3’;
Rbp3-r: 5’- GCCCAGAATCTCGTGACTC TTC -3’;
Gnat1-f: 5’– GATGCCCGCACTGTGAAAC -3’;
Gnat1-r: 5’– CCAG CGAATACCCGTCCTG -3’;
Crx-f: 5’– GTTCAAGAATCGTAGGGCGAA -3’;
Crx-r: 5’– TGAGATGCCCAAAGGATCTGT -3’.
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Chapter III

Results

Some parts of this chapter were published in this article:

Chen YC, Gatchel JR, Lewis RW, Mao CA, Grant PA, Zoghbi HY, and Dent
SYR. Gcn5 loss-of-function accelerates cerebellar and retinal degeneration in a
SCA7 mouse model.
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Short lifespan of polyQ-Atxn7 mice
To assess the role of Gcn5 in the neurodegeneration observed in a mouse
model of SCA7, I introduced different mutant alleles of Gcn5 into polyQ-Atxn7
knock-in mice that express polyQ-Atxn7 from the endogenous Atxn7 locus. I
predicted that if reduced Gcn5 function contributes to SCA7 pathogenesis,
reducing Gcn5 expression would enhance disease progression. Although the
previously reported polyQ-Atxn7 knock-in line, Atxn7266Q/5Q, nicely recapitulates
the infantile form of SCA7 (Yoo et al., 2003), disease progression in these mice
occurs rapidly, making it difficult to observe an enhancement of the already
severe SCA7 phenotypes. Therefore, to better characterize the role of Gcn5 lossof-function, I utilized SCA7 mouse lines that have a more moderate disease
progression generated by Dr. Huda Zoghbi’s lab.

The length of the CAG repeat in the Atxn7 gene correlates inversely with the
timing of disease onset, and directly with severity, so we characterized the
disease progression and the age of lethality in Atxn7 mutant mice bearing shorter
polyQ tracts (David et al., 1998; Giunti et al., 1999; Johansson et al., 1998;
Martin et al., 1999). Specifically, I compared the life span of mice bearing no
expansion in Atxn7 (Atxn75Q/5Q) to those bearing 100 CAG repeats (Atxn7100Q/5Q)
or 230 CAG repeats (Atxn7230Q/5Q) in one allele of Atxn7. Both Atxn7100Q/5Q and
Atxn7230Q/5Q mice develop previously described symptoms of SCA7 mouse
models including weight loss, kyphosis, ataxia, ptosis, tremors, gradual loss of
mobility (Yoo et al., 2003 and this study, data no shown). We recorded the age at
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which these animals died or became moribund up to 24 months. Wild type
Atxn75Q/5Q mice (wt) (Figure 2A) had a lifespan of greater than 24 months,
whereas Atxn7100Q/5Q mice had a significantly shorter lifespan (p<0.001),
averaging 18.7 months. Atxn7230Q/5Q mice died at a very early age, with a lifespan
averaging only 3.5 months (Figure 2A). The shorter lifespan of the animals
bearing longer repeats confirms the correlation between repeat length and
lethality in these mouse models of SCA7. Disease progression was accelerated
by the presence of a second polyQ-expanded allele of Atxn7, as Atxn7100Q/100Q
mice died at an earlier age than did the Atxn7100Q/5Q mice (p<0.001), with a
lifespan averaging 12.1 months (Figures 2A & 3).

Since polyQ-Atxn7 forms nuclear inclusions, I also examined whether polyQAtxn7 inclusions were formed in mice that carry 100Q-Atxn7. By immunofluoscent labeling Atxn7 in the cerebellum, signals of Atxn7 are diffuse in the
nuclei of the Purkinje cells of Atxn7100Q/5Q mice at 3 months. More condensed
Atxn7 nuclear signals appear in Purkinje cells at 6 months, while signals of
strong nuclear inclusions appeared at 1 year in Atxn7100Q/5Q mice (Figure 4).
These findings suggest that polyQ-Atxn7 progressively forms nuclear inclusions
between 6 months and 1 year of age in Atxn7100Q/5Q mice.
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Figure 2. Gcn5 mutation reduces lifespan of Atxn7100Q/5Q mice
(A) Survival rate of wild type (thin black line), Atxn7230Q/5Q (blue line), Atxn7100Q/5Q
(grey line), and Atxn7100Q/5Q;Gcn5∆/+ (green line), until 24 months of age (wt,
n=10; Atxn7230Q/5Q, n=10; Atxn7100Q/5Q, n=34; Atxn7100Q/5Q;Gcn5∆/+, n=12; *
p<0.05 between Atxn7100Q/5Q and Atxn7100Q/5Q;Gcn5∆/+, Kaplan-Meier analysis).
(B) Survival rate of wild type (thin black line), Atxn7100Q/5Q (grey line), and
Atxn7100Q/5Q;Gcn5fn/+ (dark red line), until 24 months of age (wt, n=10;
Atxn7100Q/5Q, n=34; Atxn7100Q/5Q;Gcn5fn/+, n=22; * p<0.05 between Atxn7100Q/5Q
and Atxn7100Q/5Q;Gcn5fn/+, Kaplan-Meier analysis).
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Figure 3. Lifespan of Atxn7100Q/100Q and Atxn7100Q/100Q;Gcn5∆/+ mice
Survival rate of wild type (thin black line), Atxn7100Q/100Q (thick black line), and
Atxn7100Q/100Q;Gcn5∆/+ (red line), until 24 months of age (wt, n=10; Atxn7100Q/100Q,
n=18; Atxn7100Q/5Q;Gcn5∆/+, n=12; Kaplan-Meier analysis).
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Figure 4. PolyQ-Atxn7 forms nuclear inclusion in Purkinje cells of Atxn7100Q
mice
Atxn7 was labeled using immunofluorescent staining on sagittal sections of
cerebellum of Atxn7100Q/5Q mice at 3, 6 month, or 1 year of age. Purkinje cells
were labeled using anti-Calbindin. Nuclei were labeled with Topro-3. Arrowhead
pointed to the strong signal of Atxn7 nuclear inclusion. Boxed area in picture of 1
year old cerebellum was enlarged for detailed structure.

36

Figure 4
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Altogether, these data suggest that 100Q-Atxn7 mice recapitulate human
SCA7 features and provide a suitable model to test how function of Gcn5 is
involved in neurotoxicity of SCA7.

Reducing Gcn5 shortens lifespan of polyQ-Atxn7 mice
Gcn5 null mice are embryonic lethal (Xu et al., 2000). Therefore, to assess
the role of partial loss-of-function of Gcn5 in SCA7 pathogenesis, I introduced a
hypomorphic allele of Gcn5, which reduces the level of Gcn5 expression and
activity, into Atxn7100Q/5Q mice. The hypomorphic Gcn5fn allele contains an
intronic neomycin cassette insertion that lowers Gcn5 expression to ~ 20% of
wild type levels in the homozygous state (Figure 5A & Lin et al., 2008a). Mice
homozygous for this allele can survive to adulthood, albeit at a reduced
frequency (Lin et al., 2008a). I created Atxn7100Q/5Q;Gcn5fn/fn mice and found that
the combination of these alleles resulted in lethality at postnatal day 1 (P1)
(Table 4). This early lethality indicated that concomitant diminishment of both
Gcn5 and Atxn7 functions is deleterious, but it also prohibited us from
determining the effects of altered Gcn5 functions in mature neurons.

I therefore introduced single copies of either Gcn5 hypomorphic allele
(Gcn5fn/+), or a deletion allele (Gcn5∆/+), resulting in a 50 % reduction of Gcn5
expression, into Atxn7100Q/5Q or Atxn7100Q/100Q mice (Figure 6 and Lin et al.,
2008b). In contrast to the P1 lethality of Atxn7100Q/5Q;Gcn5fn/fn animals,
Atxn7100Q/5Q;Gcn5∆/+ and Atxn7100Q/5Q;Gcn5fn/+ mice were born alive at expected
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Mendelian frequencies and had indistinguishable cage behaviors from those of
wild type littermates until the time of weaning, at 3 weeks of age. As expected,
the retina, cerebellum, and the liver of Atxn7100Q/100Q;Gcn5∆/+ mice express ~50%
level of Gcn5 in Atxn7100Q/100Q mice (Figure 6). The level of Gcn5 remains mostly
unchanged along with age in various tissues (Figure 7).
The survival of Gcn5 mutant heterozygotes was no different from that of wild
type mice (Figure 2 and data not shown), but the life span of Atxn7100Q/5Q;Gcn5∆/+
and Atxn7100Q/5Q;Gcn5fn/+ mice was significantly reduced relative to Atxn7100Q/5Q
mice (P<0.01, Figure 2). Partial loss of Gcn5 function also reduced the survival of
Atxn7100Q/100Q mice (average life span of 10.7± 7.5 months in
Atxn7100Q/100Q;Gcn5∆/+ mice compared to 12.1± 2.9 months in Atxn7100Q/100Q
mice). Interestingly, while 22 % of the Atxn7100Q/100Q mice lived over 1.5 years,
none of the Atxn7100Q/100Q;Gcn5∆/+ mice survived more than 1 year (Figure 3).
These data strongly suggest that decreased Gcn5 levels accelerate the early
adult lethality of mice bearing Atxn7100Q alleles, supporting the hypothesis that
Gcn5 loss-of-function may contribute to SCA7 pathogenesis.

Reducing Gcn5 worsens ataxia of polyQ-Atxn7 mice
Since ataxia (uncoordinated locomotion) is one of the major neurological
symptoms of SCA7 patients and mouse models (Custer et al., 2006; David et al.,
1997; David et al., 1998; Giunti et al., 1999; Yoo et al., 2003), I next asked if
reducing Gcn5 function contributes to the progression of ataxia in our SCA7
mouse model. We first examined mouse hindlimb activity using a tail suspension
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Table 4: Progeny of crosses between Gcn5flox(neo)/+ and
Atxn7100Q/5Q;Gcn5flox(neo)/+ mice
P21
Genotype
+/+

5Q/5Q

Gcn5 ; Atxn7
+/+
100Q/5Q
Gcn5 ; Atxn7
fn/+
5Q/5Q
Gcn5 ; Atxn7
fn/+
100Q/5Q
Gcn5 ; Atxn7
fn/fn
5Q/5Q
Gcn5 ; Atxn7
fn/fn
100Q/5Q
Gcn5 ; Atxn7

Number
36
31
50
39
2
0

Percent observed
(expected)
25 (12.5)
19 (12.5)
31 (25)
22 (25)
1 (1.25)
0 (1.25)

P1
Genotype
+/+

5Q/5Q

Gcn5 ; Atxn7
+/+
100Q/5Q
Gcn5 ; Atxn7
fn/+
5Q/5Q
Gcn5 ; Atxn7
fn/+
100Q/5Q
Gcn5 ; Atxn7
fn/fn
5Q/5Q
Gcn5 ; Atxn7
fn/fn
100Q/5Q
Gcn5 ; Atxn7
*Die soon after birth

Number
2
1
4
3
5*
5*

Percent observed
(expected)
10 (12.5)
5 (12.5)
20 (25)
15 (25)
25 (12.5)
25 (12.5)

E18.5
Genotype
+/+

5Q/5Q

Gcn5 ; Atxn7
+/+
100Q/5Q
Gcn5 ; Atxn7
fn/+
5Q/5Q
Gcn5 ; Atxn7
fn/+
100Q/5Q
Gcn5 ; Atxn7
fn/fn
5Q/5Q
Gcn5 ; Atxn7
fn/fn
100Q/5Q
Gcn5 ; Atxn7

Number
3
3
27
19
9
7
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Percent observed
(expected)
4 (12.5)
4 (12.5)
38 (25)
27 (25)
13 (12.5)
10 (12.5)

Figure 5. Reduced level of Gcn5 in cells of Gcn5 mutants.
Level of Gcn5 transcript normalized with β-Actin in mouse embryonic fibroblasts
from wildtype, Gcn5fn/+, Gcn5fn/fn, or Gcn5fn/∆ mice determined by Northern blot.
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Figure 6. Reduced level of Gcn5 in mice with Gcn5∆/+mutation.
Relative transcript level of Gcn5 in the retina, cerebellum and liver of wt, Gcn5∆/+,
Atxn7100Q/100Q and Atxn7100Q/100Q;Gcn5∆/+ mice determined by realtime RT PCR
(n=3 mice, *p<0.05, between wt and Gcn5∆/+, Atxn7100Q/100Q and
Atxn7100Q/100Q;Gcn5∆/+, or wt and Atxn7100Q/100Q;Gcn5∆/+). Data are presented as
mean± SD.
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Figure 7. Gcn5 RNA levels remain constant during disease progression in
Atxn7100Q/100Q and Atxn7100Q/100Q;Gcn5∆/+ mice.
Relative transcript levels to wt in the retina of wt, Gcn5∆/+, Atxn7100Q/100Q, and
Atxn7100Q/100Q;Gcn5∆/+ mice at p14, 1 month, 1.5 month and 4 month of age (n=3
mice, *p<0.05, between wt and Gcn5∆/+, or wt and Atxn7100Q/100Q;Gcn5∆/+ of same
age, Student’s t test). Data are presented as mean± SD.
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test (Lalonde, 1987). Wild type and Gcn5∆/+ mice were able to coordinate
stretching of their hind limbs when suspended by their tails (to prepare for
landing if dropped). By 7-8 months of age, 100 % (12 out of 12) of Atxn7100Q/100Q
mice also stretched their hind limbs normally upon tail suspension, while only
33.3 % (2 out of 6) of Atxn7100Q/100Q;Gcn5∆/+ mice were able to perform normally.
Interestingly, one of the four uncoordinated Atxn7100Q/100Q;Gcn5∆/+ mice
developed a severe clasping phenotype (Figure 8), and the gait of this mouse
deteriorated over time into a severe stagger, causing the mouse to frequently fall
to one side up until its death at 8 months of age. Conversely, 92 % (11 out of 12)
of Atxn7100Q/100Q mice were able to normally coordinate stretching of their hind
limbs, and no clasping phenotype was observed in these twelve Atxn7100Q/100Q
mice throughout their life.

To further evaluate the progression of ataxic gaits, I used a footprint test to
quantify changes in the gait of Atxn7100Q/100Q, Atxn7100Q/100Q;Gcn5∆/+, and wildtype
mice at 4 months and 8-9 months of age. At 4 months, I found no significant
differences between the gaits of Atxn7100Q/100Q, Atxn7100Q/100Q;Gcn5∆/+ and control
mice (data not shown). However at 8-9 months of age, both Atxn7100Q/100Q and
Atxn7100Q/100Q;Gcn5∆/+ mice walked with a significantly wider hind stance (wt, n=
5, Atxn7100Q/100Q, n=5, Atxn7100Q/100Q;Gcn5∆/+, n=3, p< 0.05, for hindbase width)
and dispersed fore- and hind-steps (p< 0.05, for paired distance) relative to wild
type mice (Figure 9). Moreover, this uncoordinated walking gait was significantly
worse in Atxn7100Q/100Q;Gcn5∆/+ and Atxn7100Q/5Q;Gcn5∆/+ mice than in
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Figure 8. Reducing the level of Gcn5 enhances clasping phenotypes of
Atxn7100Q/100Q mice.
Clasping phenotype of Atxn7100Q/100Q;Gcn5∆/+ but not Atxn7100Q/100Q or wild type
mice at 8 month of age during tail suspension test.
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Figure 8
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Figure 9. Reducing the level of Gcn5 enhances gait ataxia of Atxn7100Q/100Q
mice.
Representative traces of the gait of wild type, Atxn7100Q/100Q, and
Atxn7100Q/100Q;Gcn5∆/+ mice recorded by footprint analysis, with red and blue
footprints representing fore- and hind-paws, respectively. Uncoordinated gait of
Atxn7100Q/100Q or Atxn7100Q/100Q;Gcn5∆/+ mice at 8-9 months of age. Paired
distance (PD) measures the distance between the prints of fore- and hind-paw on
the same side. Hind-base width (HW) measures the distance between the prints
of the two hind-paws. (C) Quantified hind-base width or paired distance indicates
Atxn7100Q/100Q;Gcn5∆/+ mice have more uncoordinated walking gaits than
Atxn7100Q/100Q mice at 9 months of age (wt, n= 3; Atxn7100Q/100Q, n= 4;
Atxn7100Q/100Q;Gcn5∆/+, n= 3; *p<0.05 between wt and Atxn7100Q/100Q, wt and
Atxn7100Q/100Q;Gcn5∆/+, or Atxn7100Q/100Q and Atxn7100Q/100Q;Gcn5∆/+, KruskalWallis test). Data expressed as boxes plots (boxes, 25–75%; circles, <10 or
>90%; lines, median).
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Atxn7100Q/100Q and Atxn7100Q/5Q mice, respectively (p<0.05) (Figures 9 & 10). To
assess motor balance, Atxn7100Q/100Q, Atxn7100Q/100Q;Gcn5∆/+ and control wild type
mice were subjected to rotating rod, dowel, and wire hang tests. Although
Atxn7100Q/100Q and Atxn7100Q/100Q;Gcn5∆/+ mice showed a trend of dysfunction, the
differences observed were not statistically significant (Figure 11). These results
indicate that Atxn7100Q/5Q and Atxn7100Q/100Q mice progressively develop mild
ataxia, and that Gcn5 partial loss-of-function accelerates the onset and
progression of this ataxia in these SCA7 mouse models.

Reducing Gcn5 worsens cerebellar degeneration of polyQ-Atxn7 mice
Since cerebellar degeneration occurs in human SCA7 patients at
moderate/late stages of the disease and strongly correlates with uncoordinated
movement, I next asked whether more severe cerebellar atrophy occurred in
Atxn7100Q/100Q mice haplo-insufficient for Gcn5. The cerebellar vermis showed
mild cortical atrophy specifically in the molecular layer of lobules VI, VII and X in
both Atxn7100Q/100Q and Atxn7100Q/100Q;Gcn5∆/+ mice at 8-9 months of age,
however the atrophy was noticeably more severe in the double mutants (Figure
12). Since the molecular layer spans the dendrites or processes of Purkinje cells
and Bergmann glia, and both of these cell types are affected in SCA7 patients
and mouse models (Custer et al., 2006; Yvert et al., 2000), we performed a more
detailed analysis of these cells in the mutant mice. In particular, I focused on
lobule VI of the cerebellar vermis, in which Purkinje and glial cell activities are
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Figure 10. Gcn5 hypomorphic alleles enhance ataxia phenotypes of
Atxn7100Q/5Q mice.
(A) Clasping phenotype of Atxn7100Q/5Q;Gcn5∆/+ but not Atxn7100Q/5Q or wildtype
mice at 16 month old during tail suspension. (B) Earlier onset of uncoordinated
gait in Atxn7100Q/5Q;Gcn5fn/+, and Atxn7100Q/5Q;Gcn5∆/+ mice. Representative
walking gait of wildtype, Atxn7100Q/5Q, Atxn7100Q/5Q;Gcn5fn/+, and
Atxn7100Q/5Q;Gcn5∆/+ mice at age of 16 months recorded by footprint analysis with
red and blue footprints represent fore- and hindpaws, respectively. At 15 months
of age, both Atxn7100Q/5Q;Gcn5fn/+, and Atxn7100Q/5Q;Gcn5∆/+ mice have
uncoordinated walking gait while Atxn7100Q/5Q mice have impaired walking at 16
months of age as shown by quantified hindbase width or paired distance (wt, n=
3 ; Atxn7100Q/5Q, n= 5; Atxn7100Q/5Q;Gcn5fn/+, n= 3; Atxn7100Q/5Q;Gcn∆/+, n= 3;
*p<0.05, Kruskal-Wallis test). Data expressed as boxes plots (boxes, 25–75%;
circles, <10 or >90%; lines, median).
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Figure 11. Analysis of other motor skills of Atxn7100Q/100Q mice with Gcn5
mutations.
(A) In wire hang or dowel tests, no statistical difference was observed between
the performance of wildtype and Atxn7100Q/100Q, or Atxn7100Q/100Q;Gcn5∆/+ mice at
age of 8-9 months. N=4-6 for each genotype. Data expressed as boxes plots
(boxes, 25–75%; circles, <10 or >90%; lines, median). (B) Similar performance
on rotorod for mice all genotypes at age of 8-9 months. Wildtype, black diamond;
Gcn5fn/+, open square; Atxn7100Q/100Q, orange circle; Atxn7100Q/100Q;Gcn5fn/+,purple
circle. n=3 for each genotype. Data are presented as mean± SD.
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Figure 12. No dramatic atrophy in the cerebellum of Atxn7100Q/100Q mice with
or without a background of Gcn5∆/+ at age of 5 months.
(A) Representative images showing morphology of midsagittal cerebellar vermis
of 5 month-old wildtype, Gcn5∆/+, Atxn7100Q/100Q and Atxn7100Q/100Q;Gcn5∆/+ mice.
(B) Enlarged pictures of boxes of areas in lobule VI and X in (A) for detailed
comparison. Thickness of molecular layer (ML) was marked.
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Figure 13. Cerebellar atrophy is more severe in Atxn7100Q/100Q mice in a
background of Gcn5∆/+ at age of 9 months.
(A) Severe atrophy of molecular layer in lobule VI and X of mid saggital
cerebellar vermis of Atxn7100Q/100Q;Gcn5∆/+. Representative images showing
morphology of midsagittal cerebellar vermis of 9 month-old wildtype, Gcn5∆/+,
Atxn7100Q/100Q and Atxn7100Q/100Q;Gcn5∆/+ mice. (B) Enlarged pictures of boxes of
areas in lobule VI and X in (A) for detailed comparison. Thickness of molecular
layer (ML) was marked.
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implicated in motor coordination of the limb (de Solages et al., 2008; Harvey et
al., 1977; Nimmerjahn et al., 2009). Immunofluorescence staining revealed that
Purkinje cells have weaker Calbindin 1 expression and significantly smaller soma
size in both Atxn7100Q/100Q and Atxn7100Q/100Q;Gcn5∆/+ relative to wild type control
mice (wt, 263±42 µm2, n=3; Atxn7100Q/100Q, 228±34 µm2, n= 3;
Atxn7100Q/100Q;Gcn5∆/+, 226±50 µm2, n=2; p<0.01) (Figure 14 & 15). However,
although no statistical difference was found for overall average soma size of the
Purkinje cells between Atxn7100Q/100Q;Gcn5∆/+ and Atxn7100Q/100Q mice, 9 % of the
Purkinje cells had uncommonly small soma in Atxn7100Q/100Q;Gcn5∆/+ mice (Figure
15A). I next asked whether there is a loss of Purkinje cells in these cerebella.
The development of Purkinje cells has no significant defects in Atxn7100Q/100Q or
Atxn7100Q/100Q;Gcn5∆/+ cerebellum, since mice of all genotypes have similar
number of Purkinje cells at 5 month old (Figure 15B). At 9 months, no significant
loss of Purkinje cells occurred in Atxn7100Q/100Q (Purkinje cell count per 6 mm
sections in wt, 540± 34, n= 5; in Atxn7100Q/100Q, 514± 36, n= 4; p= 0.15).
However, Atxn7100Q/100Q;Gcn5∆/+ mice had significantly fewer Purkinje cells
(489±23, n=3) when compared to wt mice (p<0.05) at 9 months. Purkinje cell loss
was significantly worse in lobule X of Atxn7100Q/100Q;Gcn5∆/+ mice compared to
Atxn7100Q/100Q mice (Atxn7100Q/100Q;Gcn5∆/+, 22± 2, n= 3; Atxn7100Q/100Q, 27± 2, n=
4; p<0.05) (Figure 15B). In contrast, Bergmann glia exhibited similar elevated
levels of GFAP in both Atxn7100Q/100Q and Atxn7100Q/100Q;Gcn5∆/+ mice compared
to control mice (Figure 14). Together these data suggest that partial loss of Gcn5
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Figure 14. Purkinje cell morphological change is more severe in
Atxn7100Q/100Q mice in a background of Gcn5∆/+.
Anti-Calbindin 28K and GFAP antibody immunofluorescent -labeled Purkinje
cells and Bergmann glia, respectively, in cerebellar lobule VI of mice of indicated
genotype at age of 8 months.
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Figure 15. Purkinje cell degeneration is more severe in Atxn7100Q/100Q mice
in a background of Gcn5∆/+.
(A) Area size frequency of Purkinje cell soma shows Atxn7100Q/100Q and
Atxn7100Q/100Q;Gcn5∆/+ mice have smaller soma at age of 8 months (wt, n=3 mice;
Atxn7100Q/100Q, n=3; Atxn7100Q/100Q;Gcn5∆/+, n=2; *p<0.05 between wt and
Atxn7100Q/100Q, or wt and Atxn7100Q/100Q;Gcn5∆/+, Student’s t test). (B) Purkinje cell
number is similar among all genotypes at age of 5 months, while significantly less
in lobule X of Atxn7100Q/100Q and Atxn7100Q/100Q;Gcn5∆/+ mice at age of 8 months
(wt, n=3 mice; Atxn7100Q/100Q, n=3; Atxn7100Q/100Q;Gcn5∆/+, n=2; *p<0.05 between
wt and Atxn7100Q/100Q, or wt and Atxn7100Q/100Q;Gcn5∆/+, or Atxn7100Q/100Q and
Atxn7100Q/100Q;Gcn5∆/+, Student’s t test). Data are presented as mean ± SEM.
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function accelerates cerebellar and Purkinje cell degeneration, but does not
further distort Bergmann glia, in SCA7 mice.

Depletion of Gcn5 in the postnatal Purkinje neurons affects motor
coordination
In the above experiments, Gcn5 expression was decreased uniformly in all
cell types. However, in SCA7 patients the most affected neurons in the
cerebellum are Purkinje cells (Carpenter and Schumacher, 1966; Gouw et al.,
1994; Martin et al., 1994; Rub et al., 2005). Therefore to determine whether Gcn5
loss in Purkinje cells is sufficient to cause an SCA7 phenotype, I generated Gcn5
conditional knockout mice using a transgenic Cre allele expressed specifically in
Purkinje cells, Pcp2-cretg (Barski et al., 2002), and a ‘floxed’ allele of Gcn5
together with our deletion allele (Gcn5∆/f). Cre mediated recombination removes
exons 3-18 in Gcn5, resulting in a null allele (Lin et al., 2007). The resulting
Purkinje cell-specific Gcn5 conditional knock-out mice were present at Mendelian
ratios at the time of weaning. At age of P7, around the time Cre recombinase
started to express, the morphology of the cerebelli are similar among wt,
Gcn5+/f;Pcp2-cretg, and Gcn5∆/f; Pcp2-cretg (Figure 17), suggesting that there is
no developmental effect from any of these transgenic background. Using RNA in
situ hybridization or immunofluorescent staining labeling Gcn5 transcript or
protein, only minimal levels of Gcn5 transcripts were detected in Purkinje cells in
these Gcn5 conditional mice (Figure 16). These mice exhibited normal hind limb
extension in tail suspension assays, but by 11 months of age developed a mildly
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Figure 16. Purkinje cell-specific depletion of Gcn5.
(A) Immunofluorescent labeling for Gcn5 protein on section of cerebellum of
Gcn5 conditional nulls and control mice at 4 month of age. Arrowheads indicate
nuclear signals of Gcn5. Asterisks indicate Purkinje cells with weaker Gcn5
signals. Purkinje cells and nuclei were marked with Calbindin and Topro-3
staining, respectively. (B) In situ hybridization for Gcn5 transcript on cerebellar
section from 2 month old wt, Gcn5∆/+, Gcn5∆/flox;Pcp2-cretg mice. Boxes of areas
were enlarged for detailed structure.
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Figure 17. Depleting Gcn5 in Purkinje cells causes no dramatic effect in the
cerebellum at P7.
Representative pictures of mid-sagittal section of the brain or cerebellum of wt,
Gcn5+/flox;Pcp2-cretg, and Gcn5∆/flox;Pcp2-cretg mice at P7.
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uncoordinated gait with wider paired distance (Figures 18). The cerebellar vermis
in the conditional nulls appeared to be smaller than in wild type mice (Figure 19).
Since Gcn5 functions as a transcriptional coactivator, we also determined
whether loss of Gcn5 affects Purkinje cell-specific transcripts. We found that
Calbindin 1 expression was mildly decreased in Purkinje cell-specific Gcn5 null
cerebella, to 74.7 ± 5% of that in wild type animals (n=3, p<0.05) (Figure 20).
These data suggest that loss of Gcn5 in Purkinje cells mildly affects Purkinje cell
and cerebellar morphology, as well as cerebellar functions, but is not sufficient to
induce a SCA7 phenotype. These data are consistent with the primary role of
ATXN7 mutations in SCA7 disease and suggest that some other ATXN7mediated interactions, beyond those mediated by GCN5, contribute to cerebellar
pathology.

Reducing Gcn5 worsens retinal degeneration in SCA7 mice
Since the retina is another major site of neural degeneration in SCA7 patients
(David et al., 1997; David et al., 1998), we next asked whether reducing Gcn5
levels affects the progression of retinal degeneration in the SCA7 mouse model.
We examined the morphology of the retinas of control and Atxn7100Q/100Q mice
with or without Gcn5 deletion allele at postnatal day 14 (P14), 1, 2, 4, or 8
months of age. At P14, when all cell types are formed in the retina, Atxn7100Q/100Q
and Atxn7100Q/100Q;Gcn5∆/+ had retinal morphologies similar to those of control
mice (Figure 21), indicating normal retinal development had occurred. However,
by the age of 2 months, the retina of Atxn7100Q/100Q;Gcn5∆/+ mice had a thinner
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Figure 18. Purkinje cell-specific loss of Gcn5 causes mild ataxia.
(A) Coordinated hind limb stretching during tail suspension of wild type, Gcn5∆/+,
and Gcn5∆/f;Pcp2-creTg mice at 11 months of age. (B) Abnormal gait of Gcn5
conditional null mice at 11 months of age. Walking gait was recorded by footprint
analysis with red and blue footprints represent fore- and hind-paws, respectively.
Quantified footprints show Gcn5∆/f;Pcp2-creTg mice have wider paired distance
(wt, n= 3; Gcn5∆/+, n= 3; Gcn5∆/f;Pcp2-creTg, n= 3 ; *p<0.05 between wt and
Gcn5∆/f;Pcp2-creTg, Kruskal-Wallis test). Data expressed as box plots (boxes,
25–75%; circles, <10 or >90%; lines, median).
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Figure 19. Purkinje cell-specific loss of Gcn5 causes mild cerebellar
atrophy.
Smaller cerebelli in Gcn5∆/flox;Pcp2-creTg compared to that of wt mice.
Representative pictures of mid-sagittal cerebelli of Gcn5∆/+, Gcn5+/flox;Pcp2-creTg ,
and Gcn5∆/flox;Pcp2-creTg mice at age of 2, 8 and 24 month.
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Figure 20. Level of Purkinje cell-specific transcripts in Gcn5 conditional
null mice.
Relative level of Pcp2 and Calbindin1 in the cerebellum of wt, Gcn5∆/+, and
Gcn5∆/flox;Pcp2-cretg mice at were determined by realtime RT PCR (n=3 mice,
p<0.05, between wt Gcn5∆/flox;Pcp2-cretg of 2 month old, Student’s t test). Data
are presented as mean± SD.
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Figure 21. Reducing Gcn5 worsens retinal degeneration in Atxn7100Q/100Q
mice.
Representative images show progressively thinner retina in
Atxn7100Q/100Q;Gcn5∆/+ mice at 2, 4, and 8 months of age, whereas mice of all
genotypes have similar retinal structures at P14 using H&E staining. OS, outer
segment; IS, inner segment; ONL, outer nuclear layer; INL, inner nuclear layer;
GCL, ganglion cell layer.
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outer nuclear layer (ONL) when compared to those of control or Atxn7100Q/100Q
mice (Figure 21), indicating photoreceptor degeneration. Further thinning of the
ONL was observed in Atxn7100Q/100Q;Gcn5∆/+ retinas at 4 months of age, whereas
only mild thinning of the ONL was observed in retinas of Atxn7100Q/100Q mice
(Figure 21). By the age of 8 months, retinal ONLs in both Atxn7100Q/100Q and
Atxn7100Q/100Q;Gcn5∆/+ mice were dramatically thinner compared to those of the
controls. The outer segment (OS) layer started to be thinner at age of 1.5 months
in Atxn7100Q/100Q;Gcn5∆/+ retinas and appeared to be completely gone in
Atxn7100Q/100Q;Gcn5∆/+ mice at this time (Figures 21 & 22). In summary, both
Atxn7100Q/100Q and Atxn7100Q/100Q;Gcn5∆/+ mice developed retinal atrophy.
However, this retinal atrophy occurred earlier in Atxn7100Q/100Q;Gcn5∆/+ mice (first
observed at 2 months in Atxn7100Q/100Q;Gcn5∆/+ mice compared to 4 months in
Atxn7100Q/100Q mice), indicating that partial loss-of-function of Gcn5 enhances
retinal degeneration.

Reducing Gcn5 does not affect retinal degeneration in SCA7 mice
Given that transcriptional deregulation is strongly associated with
photoreceptor dysfunction and dystrophy in SCA7 mouse models (Helmlinger et
al., 2006a; Palhan et al., 2005; Yoo et al., 2003), next I asked whether decreased
Gcn5 expression induces transcriptional changes that accelerate retinal
degeneration in SCA7 mice. I focused on eight transcripts (Opn1sw, Opn1mw,
Rho, Gnat1, Rom1, Grk, Rbp3, and Cnga3) that were found previously to be
decreased in early degenerating retinas of SCA7 mouse models, and one non-
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Figure 22. Atxn7100Q/100Q;Gcn5∆/+ mice have shorter outer segment at 1.5
month of age.
Electron microscopic pictures of the retina of wt, Atxn7100Q/100Q and
Atxn7100Q/100Q;Gcn5∆/+ at 1.5 months of age. (A) 1000x magnification, and (B)
2000x magnification. PE, pigmented epithelium, OS, outer segment; IS, inner
segment; ONL, outer nuclear layer; INL, inner nuclear layer; OPL, outer plexiform
layer.
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SCA7 target (Crx) as a control (Helmlinger et al., 2006a; Palhan et al., 2005;
(Helmlinger et al., 2006a; Palhan et al., 2005; Yoo et al., 2003). RNAs were
quantified after extracted from retinas of Atxn7100Q/100Q, Atxn7100Q/100Q;Gcn5∆/+,
and control mice at P14, 1 month, 1.5 months, and 4 month of age. Consistent
with our histological results, expression of all of the SCA7 targets examined was
similar in all genotypes at P14; however, expression of these genes
progressively decreased from 1.5 to 4 months in the SCA7 mice (Figure 23). The
pattern of transcriptional decrease was consistent with that previously reported
for Atxn7266Q/5Q mice (Yoo et al., 2003). While levels of Crx transcript remained
steady, a gradual decrease of cone-specific transcripts (Opn1sw, Opn1mw),
followed by rod-specific (Rho, Gnat1, Rom1) and cone-rod shared (Grk, Rbp3)
transcripts was detected in both Atxn7100Q/100Q and Atxn7100Q/100Q;Gcn5∆/+ retinas.
Transcript levels were decreased to a similar degree in both Atxn7100Q/100Q and
Atxn7100Q/100Q;Gcn5∆/+ retinas from 1 to 1.5 months. This trend continued to 4
months of age, except that the level of Gnat1 was lower in Atxn7100Q/100Q;Gcn5∆/+
than in Atxn7100Q/100Q mice (Figure 23). Although Atxn7100Q/100Q;Gcn5∆/+ mice
undergo accelerated retinal degeneration, the finding that transcript deregulation
remains similar during early retinal degeneration in Atxn7100Q/100Q;Gcn5∆/+ and
Atxn7100Q/100Q mice suggests that reducing Gcn5 exacerbates retinal atrophy by
mechanisms other than affecting expression of known SCA7 target genes.

Potential role of Gcn5 in the late neural development
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Figure 23. Gradual decrease of SCA7 target transcripts in both
Atxn7100Q/100Q and Atxn7100Q/100Q;Gcn5∆/+ mice.
Relative transcript levels (normalized to β-actin) to wild type (dotted line) in the
retinas of Gcn5∆/+ (blue line), Atxn7100Q/100Q (red line), and Atxn7100Q/100Q;Gcn5∆/+
(purple line) mice at P14, 1 month, 1.5 months and 4 months of age (n=3 mice,
*p<0.05 or ** p<0.01 between wt and Atxn7100Q/100Q, or wt and
Atxn7100Q/100Q;Gcn5∆/+, Student’s t test). Data are presented as mean± SD.
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Knowing that Gcn5 plays an important role in maintaining normal functions of
mature neurons, I then asked whether level of Gcn5 is also critical for functions
or patterning of postmitotic neurons.
The hindbrain neurons undergo two different types of migration after being
generated by the neural progenitors and therefore are potential cells to test the
role of Gcn5 in neural migration. At E18.5, the Purkinje cells and the interneurons
of the preBotzinger complex (preBotC) in the hindbrains are generated and
migrate to their designated position in the newborn mice. Purkinje cells migrated
to the cerebellum to stimulate and guide the generation and patterning of the
granule cells. Interneurons in the preBotC connected the simulation from the
brainstem and the motor neurons in the dorsal ganglia to start and maintain
breathing pattern soon after birth. To test whether Gcn5 functions are important
in these neurons, I obtained Gcn5 hypormophic mice, which express least
amount of Gcn5 at E18.5 mice, and tested whether any defect occurred at these
two sites.

Since Purkinje cells are still immature for functions coordinating motor
behaviors at E18.5, first I tested whether cerebellar patterning is affected in Gcn5
hypomorphic mice. By H&E staining, cerebellar morphology of wt, Gcn5fn/+ and
Gcn5fn/fn mice was examined. At E18.5, the cerebellum forms in all genotypes,
however the size of the cerebellum is smaller in Gcn5 hypomorphic mice.
Furthermore, potentially lobule formation is also partly disrupted/delayed, since
less gyri were formed in the cerebellum of Gcn5 hypomorphic mice (Figure 24).
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Figure 24. Cerebellar morphology of Gcn5 hypomorphic mice at E18.5.
Representative pictures of H&E stained sagittal section of hindbrain region of wt,
Gcn5fn/+, Gcn5fn/fn mice at E18.5. The cerebellar gyri were marked with asterisks.
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I also preliminarily examined breathing functions in Gcn5 hypomorphic mice,
since disruption of preBotC development should abrogate its functions controlling
respiratory pattern. After mucus clearing and stimulation of mild touching,
wildtype and Gcn5fn/+ mice were able to start smooth breathing pattern following
short period of gasping. After smooth breathing, the lung is full of air for every
wildtype and Gcn5fn/+ mice. However, after the same clearing and stimulation
procedures, although Gcn5fn/fn mice had gasping, however % fail to transit into
smooth breathing pattern and eventually stopped gasping. As a result, the lung
contains small amount of air from gasping, however the deoxygenated blood
under skin results in darker appearance when compared to wildtype or Gcn5fn/+
littermates (Figure 25). This preliminary result that Gcn5 hypomorphic mice show
appearance that likely caused by breathing defects suggests a potential link of
Gcn5 function to neuronal patterning of BotC during hindbrain development.
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Figure 25. Differential appearance of Gcn5fn/fn mice at E18.5.
Picture of a representative litter from crossing of Gcn5fn/+ female and male after
cleaning and mild stimulation. Wildtype and Gcn5fn/+ mice showed pink
appearance and Gcn5fn/fn showed darker pink. Arrowheads point to the lightcolored lung that was expanded due to successfully breathing. Asterisks indicate
less expanded lung.
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Chapter VI

Discussion & Future Directions
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Among all 9 polyQ neurodegenerative diseases, neurotoxicity of both
Spinocerebellar ataxia type 1 (SCA1), which is caused by polyQ-ATXN1, and
Spinal Bulbar Muscular Atrophy (SBMA), which is caused by polyQ-AR, is known
to be caused by disrupted or enhanced functions of several different interactors
of the host protein (Chevalier-Larsen et al., 2004; Crespo-Barreto et al., 2010;
Duvick et al., 2010; Gehrking et al., 2011; Goold et al., 2007; Katsuno et al.,
2002; Lam et al., 2006b; Lim et al., 2008b; Mizutani et al., 2005; Tsuda et al.,
2005). Most intriguingly, polyQ-Atxn1 leads to gain- or loss-of-function in two
different interacting complexes, RMB17 and Capicua, respectively (Lam et al.,
2006a; Lim et al., 2008a). Similarly, my findings that reduced function of Gcn5
accelerates neurodegeneration in SCA7 mice suggest that polyQ-Atxn7 causes
neurotoxicity by hindering functions of the SAGA complex. My findings here with
polyQ-Atxn7 support the idea that polyQ-proteins affect the functions of
complexes interacting with the host protein, providing a shared cause of
neurotoxicity in polyQ diseases.
Mice bearing 100Q-Atxn7 show short lifespan, ataxia and photoreceptor
degeneration that resemble the major clinical signs in SCA7 patients. The adult
onset of phenotypes in these mice strongly suggests that the 100Q-Atxn7
expressing mice are good models for adult onset SCA7.
Since Purkinje cell specific polyQ-Atxn7 expression or loss of Gcn5 specifically
in the Purkinje cells (Garden et al., 2002; this work) both lack early
neurodegeneration, which distinguish these lines from mice that express polyQAtxn7 in the whole body (Helmlinger et al., 2006c; Helmlinger et al., 2004a; Lee
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et al., 2009; McMahon et al., 2005a), I propose that polyQ-Atxn7 in multiple cell
types contributes to dysfunction and neuronal loss in SCA7 mouse. Likely,
polyQ-Atxn7 leads to similar effect as loss of Gcn5 in the Purkinje cell to cause
phenotypes of similar spectrums. Notably, Bergmann glia expressing polyQAtxn7 lead to a full spectrum of neurodegeneration and ataxia, as seen in mice
expressing polyQ-Atxn7 in the full body, suggesting most of the neurotoxicity in
the cerebellum comes from toxic effects in the glial cells. Based on this
assumption, my finding that reducing Gcn5 accelerates both timing of onset and
severity of neurodegeneration in Atxn7-100Q mice suggests that partial loss of
Gcn5 function likely contributes to the toxicity caused by Bergmann glia in the
SCA7 mice.
In the SCA7 retina, a non-cell autonomous neurotoxicity can also be a
prevalent source of neurotoxicity, as several photoreceptor/retinal degenerative
diseases develop non-cell autonomous neurotoxicity (reviewed by Wright, 2010;
Bramall et al., 2010). However, no evidence yet supports this point for SCA7
retinal degeneration. Since reducing Gcn5 does not exacerbate transcriptional
down regulation of the photoreceptor-specific genes, a Gcn5-independent
mechanism must leads to this transcriptional defect in SCA7.
The evidence provided in this study supports that loss of Gcn5 functions
specifically leads to neurotoxicity regardless of its ubiquitous expression pattern,
I propose that this differential toxicity reflects differing Gcn5 functions in mitotic
and postmitotic cells. Unique functions of Gcn5 in postmitotic neurons are likely
essential to support normal neuronal functions but not survival.
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Loss of Gcn5 function contributes to neurodegeneration in SCA7 mouse
PolyQ-Atxn7 generates neurotoxicity cell-autonomously and non-cell
autonomously. Here I will discuss how altered Gcn5 functions might contribute to
neurotoxicity in both of these cases.
In this study, although decreasing level of Gcn5 is critical in accelerating
neurodegenerative phenotypes of SCA7, at this moment, it remains an
interesting question of which functions of Gcn5 are altered to cause neurotoxicity.
Currently, Gcn5 is known to have HAT and Usp22 enzymatic activity-facilitating
(Atanassov et al., 2009) functions.
In this study, although no direct evidence supports that altered Gcn5 HAT
activity is involved in neurotoxicity, my preliminary data using immunofluorescent
staining showed that total levels of acetylated histone H3K9/K14, one substrate
of Gcn5, is reduced in the Purkinje cells of both Atxn7100Q/100Q and Gcn5f/∆;Pcp2cretg mice at 4 months of age (data not shown). Since Gcn5 is one of the HATs
responsible for acetylation of H3K9/K14, its HAT activity could potentially be
reduced in SCA7 affected neurons. Therefore potentially, identifying functions of
substrates of Gcn5 in the neurons maybe a key to understanding neurotoxicity of
SCA7. However interestingly, loss of Gcn5 in the Purkinje cells leads to only mild
cerebellar dysfunction, which suggests that Gcn5 functions may be at least partly
redundant in the Purkinje cells. Potentially, the highly similar paralog of Gcn5 in
mammals, PCAF, could complement loss of Gcn5, since it has similar conserved
HAT activity and is also expressed in the same cell populations. If this were the
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case, depleting both Gcn5 and PCAF would cause a more severe neuronal
defect in the Purkinje cells then Gcn5 depletion alone.
Since Gcn5 also functions to facilitate the DUB activity of Usp22 in SAGA, it is
highly possible that this DUB activity is affected in SCA7 neurons. Atxn7 is part of
the DUB module. Although no direct evidence yet shows that abnormal DUB
activity is critical to neurotoxicity in SCA7, the abnormal accumulation of
ubiquitin/ ubiquitinated proteins in polyQ diseases agues a lower rate of
deubiquitination. Although this accumulation of ubiquitin occurs in both
degenerating and non-degenerating cells, it is still possible that the abnormal
aggregation of ubiquitin is associated with neuron-specific toxicity in SCA7. Next
I will discuss this possibility in detail.

Potential role of ubiquitin and Usp22 DUB activity in SCA7
Intra- or interneuronal aggregation of ubiquitinated proteins, for example, Lewy
bodies and neurofibrillary tangles, is widely observed and identified as
serological features that associate with neurodegenerative diseases (reviewed by
Alves-Rodrigues et al., 1998). Also, defects in the ubiquitin and unfolded protein
turnover systems, such as chaperones and the ubiquitin-proteasome system, has
been shown to lead to neurotoxicity (reviewed by Ciechanover and Brundin,
2003; Muchowski and Wacker, 2005). Defects in ubiquitin ligases, such as
UBE3A, UBE1, Parkin, and deubiquitinases, such as ATXN3, Usp14, and
UCHL1, have been linked to neurodegeneration (Imai et al., 2000; Kishino et al.,
1997; Milla et al., 2002; Saigoh et al., 1999; Wilson et al., 2002; Wintermeyer et
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al., 2000), suggesting imbalance in homeostasis of ubiquitin and ubiquitinated
proteins could drive neurotoxicity.
In earlier studies, the accumulation of ubiquitin was hypothesized as an
indicator of disrupted proteasomal functions in Alzheimer’s disease and as an
inducer of both formation of nuclear inclusions and cell death in polyQ
neurodegenerative diseases (de Pril et al., 2004; Fischer et al., 2003). However
one later study clearly showed that normal activity of the proteasome exists
through out the neuropathology in affected photoreceptors of SCA7 mice
(Bowman et al., 2005). This finding suggests that SCA7 neurons potentially have
abnormal homeostasis of ubiquitin, rather than a problem in protein turnover per
se, that may result from defects in deubiquitinase or ubiquitin ligase activities.
Although it is not clear how abnormal ubiquitin aggregation might be related to
generation of polyQ neurotoxicity in the disease state, several reports suggested
healthy mature neurons utilize ubiquitin differentially. Mature neurons that have
exited the cell cycle require plasticity and the ability to reset synaptic functions
and chromatin modifications potentially via utilizing ubiquitin modification. If these
processes are critical for neuronal functions, it maybe a key to answer whether
and how unbalanced ubiquitin leads to neurotoxicity. This difference in utilizing
ubiquitin among various cell types could potentially determine the differential cell
vulnerability in neurodegenerative diseases. One recent study showed that
neurons maintain distinctively higher amount of free ubiquitin than other cell
types (Kaiser et al., 2011). This evidence suggested that although ubiquitin is
ubiquitously utilized in all cell types, postmitotic neurons likely utilize the ubiquitin
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proteasome system distinctively from other cell types. One potential biological
function of higher level of ubiquitin in mature neurons might be for maintaining
the postmitotic status. Previously, the level of free ubiquitin was found associated
with ubiquitin status of histone H2A in mammalian cells (Dantuma et al., 2006).
More recently, the level of Ub-H2B, which is highly regulated by E3-Ub-DUB
which involves in removing ubiquitin, is critical for normal chromatin packing
(Fierz et al., 2011). These findings along with the evidence that upon deficiency
of enzymes of the ubiquitin proteasome system, postmitotic neurons undergo
apoptosis accompanied with aberrant de novo DNA synthesis (Staropoli and
Abeliovich, 2005), suggests that postmitotic neurons likely utilize ubiquitin
proteasome system to maintain unique Ub status on chromatin for preventing
chromatin decondensation and reentry into the cell cycle. Further understanding
of this under-explored area of protein ubiquitination imbalance in
neurodegeneration will require greater definition of the enzymes catalyzing
ubiquitination and deubiquitination in neurons.
Interestingly, a link between neurodegeneration and decondensed chromatin
that might be associated with an unbalanced free Ub pool was observed SCA7
transgenic mice in that heterochromatic structures were opened in severely
affected neurons (Helmlinger et al., 2006a). However this phenomenon might
also be a late pathological event and not the cause of early cytotoxicity, as in our
slow-progressing SCA7 mouse, no disrupted heterochromatin was observed in
early degenerating neurons (Fig 22). Depleting GCN5 reduces the enzymatic
activity of USP22 (Atanassov et al., 2009). My preliminary immunofluorescent

99

staining data showed mild accumulation of ubiquitinated proteins in Gcn5-null
Purkinje cells, suggesting that loss of Gcn5 also affects turnover of ubiquitinated
proteins, potentially by obstructing activity of Usp22. Disrupted functions of
Usp22 DUB, which regulates the Ub status of its specific targets, such as histone
H2A and H2B as well as potentially the free Ub pool (reviewed by Shabek and
Ciechanover, 2010), could be involved in SCA7 neuropathy, perhaps causing the
late unpacking of heterochromatin.

Implication of non-transcriptional functions of Gcn5/SAGA involved in the
early degenerating retina of SCA7.
SAGA complex is best known for its transcriptional coactivator functions
through its HAT and DUB activities. Although previous studies based on yeast
and cultured mammalian cells indicate that polyQ-Atxn7 disrupts transcriptional
coactivator functions of SAGA (Helmlinger et al., 2006c; Helmlinger et al., 2004a;
Lee et al., 2009; McMahon et al., 2005a), evidence provided in this study argues
that such changes are only marginally due to loss of Gcn5.
The early defects in the degenerating neurons should be the primary cause of
neurotoxicity in SCA7. Intriguingly, with accelerated retinal degeneration, the
pattern of transcriptional down regulation of SCA7 targets was not further
changed in the retina of Atxn7100Q/100Q mice expressing less Gcn5 (Figures 2022). These data suggest that partial loss of Gcn5 function might contribute to
retinal pathogenesis through affecting other targets than those tested here, which
were previously defined as down regulated in SCA7 retinas. Although other, yet
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to be defined transcriptional targets of Gcn5 may be involved in SCA7, the
possibility also remains that non-transcriptional targets of Gcn5/SAGA direct the
accelerated retinal degeneration in SCA7 mice depleted of Gcn5. Therefore
identifying transcriptional and non-transcriptional targets of Gcn5/SAGA will give
insights to how polyQ-Atxn7 causes neurotoxicity. Secondly, since downregulation of Opn1sw, Opn1mw, and Rho likely causes photoreceptor
dysfunction in SCA7 (Yoo et al., 2003), the lack of additional effects on
transcriptional down-regulation of these genes in Atxn7100Q/100Q;Gcn5∆/+ mice
suggests that altered function of Gcn5 is not the sole contributor of SCA7
neurotoxicity. Likely a Gcn5-independent mechanism underlies this
transcriptional down regulation in SCA7. The independence of Gcn5 level in the
transcriptional down regulation of SCA7 targets could also be the reason why two
previous reports found divergent enrichment/function of Gcn5 during
transcriptional down regulation in SCA7 retina (Helmlinger et al., 2006a; Palhan
et al., 2005).
Since Atxn7 is part of DUB submodule of SAGA, possibilities are that functions
of the DUB module are also altered by polyQ-Atxn7. Previous evidence provided
by Atanassov et. al. suggests that the DUB function of USP22 also regulates
protein stability (Atanassov et al., 2009). My data suggests the potential
involvement of non-transcriptional functions of SAGA in SCA7 pathogenesis,
hence Usp22 functions in regulating protein stability may well be involved in
neurotoxicity of polyQ-Atxn7.
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In sum, my data suggest examining transcriptional and non-transcriptional
functions of SAGA/Gcn5 in neurons will point out the potential pathways affected
by polyQ-Atxn7.

Future direction- determine the functions of Gcn5 in photoreceptors and
Bergmann glia in SCA7 neuropathogenesis
Since loss of Gcn5 function leads to neurotoxicity in SCA7 mice, finding
targets of Gcn5 will expedite discovering therapeutics for SCA7. Evidence that
decreased functions of Gcn5 accelerate degeneration of the photoreceptors in
SCA7 mice (Figures 20 & 21) suggests that Gcn5 loss of function contributes to
polyQ-Atxn7 neurotoxicity in photoreceptors. Since depletion of Gcn5 in Purkinje
cells leads to only mild neuropathy, reduced function of Gcn5 potentially also
affects Bergmann glia and leads to non-cell autonomous toxicity of Purkinje cells
in SCA7. Therefore, I propose to identify genomic and protein targets of Gcn5 in
photoreceptors and Bergmann glia, two cell types that are likely affected by
neurotoxicity from hindered functions of Gcn5.
To identify transcriptional targets of Gcn5 that are involved in neurotoxicity of
photoreceptors, I will utilize Biotin-tagged Gcn5 to determine the genomic loci
associated with Gcn5 in these cells. Biotin-tagged Gcn5 provides stronger and
more specific chromatin immunoprecipitation (ChIP) signals than the commercial
Gcn5 antibodies available (Hirsch & Dent, personal communication). I will cross a
Biotin-Gcn5 transgene, CAG-stop-Biotin-Gcn5tg, which conditionally expresses
Biotin-Gcn5 under control of Cre recombinase, into Crx-cretg, or
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Atxn7100Q/100Q;Crx-cretg mice. Since Crx promoter only drives expression of Cre
recombinase in the photoreceptors, this crossing will allow photoreceptor-specific
expression of Biotin-tagged Gcn5. The altered Gcn5 enriched genomic loci in
SCA7 photoreceptors can then be identified by ChIP-seq for biotin using whole
retinas. The targets of Gcn5 obtained from ChIP-seq can be confirmed by testing
whether their transcripts are altered transcripts in the photoreceptors of Gcn5
conditional null and SCA7 mice. To determine the profiles of transcripts, RNAseq using RNA from retinas of Crx-cretg, Gcn5flox/flox;Crx-cretg, and
Atxn7100Q/100Q;Crx-cretg mice will be compared.
Next, the protein substrates of Gcn5 will be identified by enriching acetylated
proteins from photoreceptors. To do this, photoreceptors will be marked by
fluorescent protein, EGFP that is expressed by Crx-EGFPtg, and sorted by FACS.
The acetylated protein can then be enriched by immunoprecipitation (IP) using
anti acetyl-lysine antibody from the protein lysates of these cells. The acetylated
proteins will then be separated by 2-D gel for better resolution of individual
proteins. To identify Gcn5 substrates, I will compare the 2-D gel patterns of
acetylated protein enriched from Gcn5flox/flox; Crx-cretg; Crx-EGFPtg and Gcn5+/+;
Crx-cretg; Crx-EGFPtg. I expect to see some of the acetylated proteins are less
abundant in Gcn5 null photoreceptors. The acetylated proteins that are
differentially abundant will further be isolated and identified by mass
spectrometry (MS). To further confirm if the identified protein substrates of Gcn5
are differentially acetylated in polyQ-Atxn7 photoreceptors, I will compare the
abundance of in enriched acetylated proteins in the photoreceptors of
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Atxn7100Q/100Q and wildtype mice using protein-specific antibody. The aceylated
proteins that potentially associate with SCA7 neurotoxicity are likely identified in
both Gcn5-tagged and SCA7 mice.
To test whether Gcn5 leads to defect in Begmann glia, which in turn leads to
abnormal cerebellar function, I propose to use Bergmann glia-specific cre
transgene (Custer et al., 2006) to drive conditional depletion of Gcn5 in
Gcn5∆/flox;Gfa2-cretg;Gfap-EGFPtg mice. Motor coordination of these mice could
be examined and compared to that of Atxn7100Q/100Q mice. To identify Gcn5
transcriptional targets that potentially associate with cerebellar functions, RNAseq can be used to identify transcript profile of FACS sorted EGFP-positive
Bergmann glia enriched from cerebellum of Gcn5∆/flox;Gfa2-cretg;Gfap-EGFPtg
mice. To further confirm which transcriptional targets of Gcn5 are affected in the
Bergmann glia of SCA7 mice, RNA-seq and ChIP-seq would be used to
determine the profile of transcripts and Gcn5 enrichment in the genome,
respectively, in FACS-sorted Bergmann glia from mice with transgene expresses
Biotin-tagged Gcn5 in Atxn7100Q/100Q;Gfap-EGFPtg background and BiotinGcn5tg;Gfap-EGFPtg mice.
Acetylation of HAT substrates of Gcn5 is likely lower in Gcn5 null cells. Thus
the acetylated substrates of Gcn5 should be less abundant in Gcn5 null cells
compared to that of wildtype cells. A pull-down assay using anti-acetylated lysine
antibody could be used to catch acetylated proteins in enriched Bergmann glia.
Protein targets of Gcn5 HAT in the Bergmann glia could then be identified by
comparing the pattern of acetylated proteins separated by 2-D gel using lysates
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from Bergmann glia of Gcn5∆/flox;Gfa2-cretg;Gfap-EGFPtg and Gcn5+/+;Gfa2cretg;Gfap-EGFPtg mice. The acetylated proteins that are differentially abundant
will further be identified by mass spectrometry (MS).
The evidence provided by proposed experiments will determine the targets of
Gcn5 in the photoreceptor and Bergmann glia that potentially involves in SCA7
neuropathy.

Future direction- Role of Usp22 in SCA7
The clear role of loss-of-Gcn5 function in pathogenesis of SCA7 mice
demonstrated in this study pointed Gcn5 as the potential therapeutic target.
Moreover, knocking down Gcn5 does not disrupt overall SAGA integrity
(Atanassov et al., 2009) but does cause depletion of the other enzymatic activity,
DUB of Usp22, of SAGA. In addition, Atxn7 is in the DUB submodule that Usp22
resides in. Therefore, altered functions of Usp22 could also involve in
neurotoxicity of polyQ-Atxn7. Testing the role of Usp22 involvement in the SCA7
pathogenesis using genetic strategy will address this question. Since knocking
down GCN5 reduces USP22 activity (Atanassov et al., 2009), part of the
enhanced phenotypes of SCA7 mice by reducing Gcn5 could be contributed by
Usp22 loss-of-function. Therefore, at this point, it is fair to ask whether loss of
functions of Usp22 also involves in neurotoxicity; and what are the proteins
Usp22 affects.
Usp22 null mice likely die as embryos (preliminary data from Koutelou & Dent,
personal communication), therefore to test the role of losing Usp22 function in
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mature neuronal tissues in adult mice, I will utilize conditional alleles. Introducing
conditional Usp22 alleles that reduce level of Usp22 specifically in the Purkinje
cells, Bergmann glia, or the photoreceptors would answer whether loss of Usp22
function involves in cerebellar or retinal degeneration. The Purkinje cell,
Bergmann glial, or photoreceptor conditional Usp22 depletion mice would carry
Usp22flox/flox;Pcp2-cretg, Usp22flox/flox;Gfa2-cretg, Usp22flox/flox;Crx-cretg, or
respectively. Cerebellar or retinal functions of these mice can then be determined
by rotarod, footprint, dowel, and wire hang tests for motor coordination; and
electroretinography for photoreceptor electrical responses.
To determine the potential substrates of Usp22 in the neurons and glias, I
propose to identify the hyper-ubiquitinated proteins in Usp22 null cells compared
to wildtype cells. In order to purify ubiquitinated proteins, Usp22 conditional null
mice will be introduced with 6xHis-tag ubiquitin (Ub) reporter transgene that also
conditionally expressing his-tagged Ub under control of the cre recombinase that
is expressed in the cell type of interest. Since His-tagged Ub is only expressed in
the cell types of interest, no further cell type enrichment is required prior to
protein extraction. However, to prevent fast proteasome-mediated degradation of
ubiquitinated proteins, injections of proteasome inhibitors into the vitreous cavity
or brain ventricles may be necessary for the retina or cerebellum, respectively.
Nuclear or cytosolic fraction of His-tagged ubiquitinated proteins can be purified
using Ni2+-affinity chromatography-purified and then subject to mass
spectrometry (MS) for peptide identification.
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Identifying targets of Usp22 will further suggest potential role of this DUB in
neuronal functions and provide insight in how Usp22 involves in neurotoxicity.
Revealing whether and how Usp22 involves in neurodegeneration will not only
provide targets for designing small molecule drugs for SCA7 patients, but also
suggest potential mechanisms that might shared between neurodegenerative
diseases with defects in ubiquitin turnover.

Potential role of Gcn5 in immature neurons
Since Gcn5 is highly expressed in the hindbrain (RNA in situ data from Allen
Brain Institutes), Gcn5 likely also functions in the neurons of the hindbrain during
late embryonic development. The preliminary evidence obtained with Gcn5
hypomorphic mice (Figures 23-24) here also suggested that Gcn5 likely has
important role during hindbrain development.

Future direction- role of Gcn5 in immature neurons in the hindbrain
Previous evidence in Drosophila suggests that Usp22 (or Nonstop in
Drosophila) SAGA complex is involved in neurite projection (Weake et al., 2008).
This evidence strongly suggests that function of SAGA is involved in
development of nervous system.
The preliminary results in my work suggest that proper level of Gcn5
potentially is essential for normal hindbrain development. Specifically, cerebellum
and preBotC, the nucleus controls and starts breathing patterns, are likely being
affected in Gcn5fn/fn mice at E18.5 (Figures 23 & 24). To this end, I will ask which
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processes during hindbrain development does Gcn5 involve in; and what are the
substrates of Gcn5 in these neurons. Identifying Gcn5 targets in various cell
types can give further understanding on how polyQ diseases leads to differential
neurotoxicity and adult-onset neurodegeneration.
The development of hindbrain requires proper neurogenesis, migration,
neurite projection and synapse connection. Therefore, to determine which steps
Gcn5 is involved in, I propose to examine whether there is any defect in each
processes occurred in Gcn5fn/fn mice. To test if Gcn5 mutant has similar
neurogenesis compared to wildtype mice, BrdU and anti-phospho-histone
H3ser10 antibody labeling will mark proliferating cells in cerebellum and
brainstem of E18.5 embryos. To determine whether there is a defect in migration
of these neurons then leads to abnormal patterning, anti-neurokinin 1 receptor
(NK1R) or Calbindin1 (Calb1) antibody labeling will mark interneurons of preBotC
or cerebellum for its position. Since these markers are cytoplasmic or
membranous, they can also determine the shapes of neurons and their neurites.
To determine whether correct neurite connections were made in brainstem of
Gcn5fn/fn mice, single neuron electrophysiology examination will answer the
question however it requires specialty equipments and personal.
Specific sets of genes are expressed for each cellular function during
neuronal development. Therefore, the transcriptional coactivator function of Gcn5
is likely involved in turning on certain genes during hindbrain development. To
identify Gcn5 targets in the neurons of hindbrains at E18.5, the Gcn5-bound DNA
regions can be identified by ChIP-seq after enrichment by Straptavidin-
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immunoprecipitation from hindbrain of the mice carrying the transgene that
expresses Biotin-tagged Gcn5 (Biotin-Gcn5tg). The targets of Gcn5 can be further
confirmed by analyzing the profile of transcripts in E18.5 Gcn5fn/fn mice using
RNA-seq analysis. The gene ontology of Gcn5 targets will suggest the pathways
and the processes that Gcn5 might regulate. The evidence provided by the
proposed experiments will give the first glance of how Gcn5 is involved in
neuronal development.
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